MedTrace Logo

Bupropion Alone or Combined With Nicotine Gum

NCT01621022 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 608

Last updated 2016-12-06

No results posted yet for this study

Summary

Focus of this study was to determine if bupropion was more effective for smoking cessation when used alone or combined with nicotine gum.

Conditions

  • Tobacco Dependence

Interventions

DRUG

bupropion + nicotine gum

150 mg bupropion twice daily plus 4 mg nicotine gum as needed (up to 12 pcs/day)

DRUG

Active bupropion-Placebo gum

150mg bupropion twice daily plus placebo nicotine gum as needed (up to 12 pcs/day)

DRUG

Placebo bupropion-Placebo gum

Placebo bupropion twice daily + placebo nicotine gum as needed (up to 12 pcs/day)

Sponsors & Collaborators

  • National Institutes of Health (NIH)

    collaborator NIH

  • University of Wisconsin, Madison

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2001-01-31
Primary Completion
2002-10-31
Completion
2002-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01621022 on ClinicalTrials.gov